And science team American developed a new approach in cell therapy. The investigator Khalid Shahdel Brigham and Women’s Hospital de BostonMassachusetts, explained that this new method is able to eliminate tumors and, at the same time, induce the immunity long-term. This I would do it by training immune system and thus avoid the reappearance of the cancer.
Los researchers they already tested the vaccine double action anticancer drug that they produced. They were tested in an advanced mouse model of glioblastoma, a cancer lethal brain injury, achieving promising results. All these works were published in “Science Translational Medicine“an interdisciplinary medical journal of the United States of America.
Shahsaid that his team “has pursued a simple idea: take cancer cells and turn them into vaccines and cancer killers.” In addition, he explained that they did “through genetic engineering, we are reusing cancer cells to develop a therapeutic that kills tumor cells and stimulates the immune system to both destroy primary tumors and prevent cancer.” The theme of the vaccines is one of the main aspects of research against cancer for many laboratories, but what characterizes this work is its approach.
It is methodinstead of using tumor cells inactivated, use living cells, with an unusual feature. They explain that the operation is similar to that of homing pigeons, being these living cells those who on their way to the tumorrelease a destructive agent of tumor cells.
This therapy double action, applied to the models, was safe, applicable and effective. In this way, a new path is marked out in the direction of therapy against cancer. Likewise, it requires more testing and development, but a big step was the work done by the Shahby choosing this specific model and by using human cellsthus paving the way for transferring his findings to patients.